Allogeneic stem cell transplantation for non-de novo AML or advanced myelodysplastic syndromes: influence of GvHD and donor lymphocyte infusions on long-term outcome
Crossref DOI link: https://doi.org/10.1038/bmt.2017.215
Published Online: 2017-10-09
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hemmati, P G
Pfeifer, K
Vuong, L G
Jehn, C F
Terwey, T H
le Coutre, P
Dörken, B
Arnold, R
Text and Data Mining valid from 2017-10-09
Version of Record valid from 2017-10-09
Article History
First Online: 9 October 2017
Competing interests
: The authors declare no conflict of interest.